Frequently Asked Questions
Common Questions About Using ICD-10 Code G70.2 for Congenital and developmental myasthenia
What are the common symptoms of congenital and developmental myasthenia?
Common symptoms include muscle weakness that worsens with activity, drooping eyelids, double vision, and difficulty swallowing. These symptoms can significantly impact daily activities and require careful management.
How is congenital and developmental myasthenia diagnosed?
Diagnosis typically involves a clinical evaluation, patient history, and may include tests such as electromyography (EMG) and genetic testing to confirm neuromuscular junction defects.
What treatments are available for congenital and developmental myasthenia?
Treatment options include acetylcholinesterase inhibitors to enhance neuromuscular transmission, physical therapy for muscle strengthening, and monitoring for respiratory function.
Is congenital and developmental myasthenia hereditary?
Yes, congenital and developmental myasthenia is often hereditary, resulting from genetic mutations that affect neuromuscular transmission. Family history may be a significant factor in diagnosis.
